Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Honigman says it advises 3i on Cerenome facility of up to $20 million
Honigman announced that it had represented 3i, LP in a senior secured financing facility of up to $20 million for Cerenome. The firm said the arrangement used royalty-based repayments and combined initial funding at closing with further advances dependent on specified milestones being achieved.
Key points
- Honigman described Cerenome as an oncology company working on diagnostics, therapeutics and AI.Honigman
- The firm named Michael Rosenberg and Danny Shulman as corporate team leaders.Honigman
- The announcement identified Clara Seymour and Aviv Avnon as finance partners on the matter.Honigman
- Honigman’s notice did not specify the amount funded at closing.Honigman